• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    U.S. Physical Therapy Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    3/13/26 4:07:53 PM ET
    $USPH
    Medical/Nursing Services
    Health Care
    Get the next $USPH alert in real time by email
    falseU S PHYSICAL THERAPY INC /NV000088597800008859782026-03-092026-03-09


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549


    FORM 8-K


     CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): March 9, 2026


     U.S. PHYSICAL THERAPY, INC.
    (Exact name of registrant as specified in its charter)


    Nevada

     
    001-11151

     
    76-0364866

    (State or other jurisdiction
    of incorporation or organization)
     
    (Commission
    File Number)
     
    (I.R.S. Employer
    Identification No.)

    1300 WEST SAM HOUSTON PARKWAY SOUTH,
    SUITE 300, HOUSTON, Texas
     
    77042

    (Address of Principal Executive Offices)
     
    (Zip Code)

    Registrant's telephone number, including area code: (713) 297-7000

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐
    Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
       
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock, $.01 par value

    USPH

    New York Stock Exchange


    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     
    Emerging growth company
    ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
    ◻



    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Compensatory Arrangements of Executive Officers

    Effective March 9, 2026 (“Effective Date”), the Compensation Committee of the Board of Directors (the “Committee”) as defined in Section 1.8 of the U. S. Physical Therapy, Inc. (“USPH”) 2003 Stock Incentive Plan (the “2003 Plan”) approved and adopted the incentive plans for senior management as described below. Members of senior management who are eligible under the incentive plans include Mr. Christopher Reading, Chairman and Chief Executive Officer (“CEO”), Mr. Eric Williams, President and Chief Operating Officer - East (“President”), Mr. Graham Reeve, Chief Operating Officer – West (“COO West”), and Mr. Rick Binstein, Executive Vice President, General Counsel and Secretary (“EVP”), (hereinafter collectively referred to as “Executives”).
    Objective Long-Term Incentive Plan for Senior Management for 2026 (“Objective LTIP”): Under the Objective LTIP, Executives have an opportunity to receive Restricted Stock Units (“RSUs”) under the 2003 Plan to be granted by the Committee in the first quarter of 2027 (“Grant Date”). Each RSU represents the right to receive one share of Common Stock upon settlement. If prior to the settlement date, the Company declares a cash or stock dividend with respect to shares of Common Stock, then on the payment of such dividend the Grantee will be credited with “Dividend Equivalents” in an amount equal to the dividends that would have been paid to the Grantee if one share of Common Stock had been issued on Grant Date for each RSU. Such Dividend Equivalents are subject to the same transfer restrictions, vesting conditions, and forfeiture provisions as the related RSUs. Dividend Equivalents will be paid in cash, including cash equivalents of any stock dividends, at the time the RSUs vest and are settled. Executives must remain employed by the Company or its affiliates from the effective date through the applicable grant date to receive RSU awards, unless otherwise provided in an employment agreement.

    RSUs are granted under the Company’s 2003 equity incentive plan and are subject to terms and conditions established by the Committee, including transfer restrictions and forfeiture provisions. RSUs vest in equal quarterly installments over 16 quarters beginning May 20, 2027 and continuing August 20, November 20, and March 6, with final vesting on March 6, 2030. Vesting may accelerate upon a “Qualified Retirement,” defined as separation from service after age 65 with at least eight years of service, provided the executive gives at least nine months’ advance written notice. In the event of a Qualified Retirement, vested units and any related Dividend Equivalents will be settled or paid six months following the executive’s termination of employment.

    The Compensation Committee determines the amount, if any, of the RSUs to be granted to each Executive and shall be based on the Company’s achievement of Adjusted EBITDA for the year 2026.  Adjusted EBITDA is defined as net income attributable to USPH shareholders before interest income, interest expense, taxes, depreciation, and amortization, changes in revaluation of put-right liability, equity-based awards compensation expense, any impairment charges and other extraordinary or unusual items, and related portion for non-controlling interests. The target number of RSUs that may be granted are as follows: CEO = 12,752 RSUs; President = 5,613 RSUs; COO West = 5,080 RSUs and EVP = 4,314 RSUs. The maximum amount of RSUs awarded could be up to 150% of the target number of RSUs.

    Discretionary Long-Term Incentive Plan for Senior Management for 2026 (“Discretionary LTIP”): In addition to any other awards under the 2003 Plan or any other long term incentive plan or bonus plan, policy, or program of USPH, and not in lieu of any other such award or payment, the Committee may, in its judgment and at its sole discretion, to incentivize and retain Executives, grant RSUs under the 2003 Plan, based on its evaluation of an Executive's performance and the collective corporate performance for 2026.

    Any RSU granted under this program shall be awarded in the first quarter of 2027.  Each RSU represents the right to receive one share of Common Stock upon settlement. If prior to the settlement date, the Company declares a cash or stock dividend with respect to shares of Common Stock, then on the payment of such dividend the Grantee will be credited with “Dividend Equivalents” in an amount equal to the dividends that would have been paid to the Grantee if one share of Common Stock had been issued on Grant Date for each RSU. Such Dividend Equivalents are subject to the same transfer restrictions, vesting conditions, and forfeiture provisions as the related RSUs. Dividend Equivalents will be paid in cash, including cash equivalents of any stock dividends, at the time the RSUs vest and are settled.  Executives must remain employed by the Company or its affiliates from the effective date through the applicable grant date to receive RSU awards, unless otherwise provided in an employment agreement.

    RSUs granted under the Company’s 2003 equity incentive plan are subject to terms and conditions established by the Committee, including transfer restrictions and forfeiture provisions. Awards vest in equal quarterly installments over 16 quarters beginning May 20, 2027, and continuing August 20, November 20, and March 6, with final vesting on March 6, 2030. Vesting may accelerate upon a “Qualified Retirement,” defined as separation from service after age 65 with at least eight years of service, provided the executive gives at least nine months’ advance written notice. In the event of a Qualified Retirement, vested units and any related dividend equivalents will be settled or paid six months following the executive’s termination of employment. The number of RSAs that may be granted is subject to the evaluation of the Executive’s performance and the collective corporate performance during 2026. The maximum number of RSUs that may be granted are as follows: CEO = up to 19,128  RSUs; President = 8,419 RSUs; COO - West = 7,619 RSUs;  and EVP = up to 6,473 RSUs.

    Objective Bonus Plan for Senior Management for 2026 (“Objective Bonus Plan”): Under this Objective Bonus Plan, Executives have an opportunity to receive either a “Cash Bonus” Award or Restricted Stock Awards (“RSA”) having a value at the time of the Award of up to 100%, of the CEO’s annual base salary for 2026, and up to 75% of the annual base salary for 2026 for the President, COO West and the EVP as Performance Awards under the 2003 Plan. The Committee will, in its sole discretion, determine the amount and type of award to be made in the first quarter of 2027.  No Executive will be entitled to any type of award or have a legally binding right to an award until the Committee, in its sole discretion, determines an award will be made, the amount and the type of award to be made. No Executive will be entitled to elect between the Cash Bonus and RSA.

    Before any Cash Bonus is made or an RSA is awarded under this Objective Bonus Plan, the Committee shall certify in writing that the performance goals (which in this case is the achievement of certain level of Adjusted EBITDA) have been obtained. Adjusted EBITDA is defined as net income attributable to USPH shareholders before interest income, interest expense, taxes, depreciation, and amortization, changes in revaluation of put-right liability, equity-based awards compensation expense, any impairment charges and other extraordinary or unusual items, and related portion for non-controlling interests. Any Cash Bonus award made hereunder shall be paid in a lump-sum amount, and any RSA granted, in each case no later than March 15, 2027. The Executive must be continuously employed by USPH or its affiliates from the Effective Date through December 31, 2026, to receive the Cash Bonus or an RSA.

    Discretionary Cash/RSA Bonus Plan for Senior Management for 2026 (“Discretionary Bonus Plan”):’ ; In addition to awards under any other plan or program at USPH for which such Executives are eligible and not in lieu thereof, each Participant in this Discretionary Bonus Plan has the potential to be awarded of up to 50% of the Participant's annual base salary for 2026 (“Subjective Bonus”) subject to the achievement of individual goals established by the Committee. The Subjective Bonus shall be made as either a Cash Bonus Award or RSAs, as determined in the sole discretion of the Committee. No Participant shall be entitled to a Subjective Bonus and shall have no legally binding right to a Subjective Bonus until the Committee determines the amount and type of award to be made.  No Participant will be entitled to elect any type of award to be made. Any Cash Bonus made hereunder shall be paid in a lump-sum amount, and any RSA granted, in each case no later than March 15, 2027. The Executive must be continuously employed by USPH or its affiliates from the Effective Date through December 31, 2026, to receive the Cash Bonus or an RSA.

    The foregoing descriptions are qualified in its entirety by reference to the full text of each of the Objective LTIP, Discretionary LTIP, Objective Bonus Plan, and Discretionary Bonus Plan, which are filed as Exhibits 99.1, 99.2, 99.3 and 99.4, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

    ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS

         
    Exhibits
     
    Description of Exhibits
       
    99.1*
     
    U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2026, effective March 9, 2026.
    99.2*
     
    U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2026, effective March 9, 2026
    99.3*
      U. S. Physical Therapy, Inc. Objective Cash/RSA Bonus Plan for Senior Management for 2026, effective March 9, 2026.
    99.4*
      U. S. Physical Therapy, Inc. Discretionary Cash/RSA Bonus Plan for Senior Management for 2026, effective March 9, 2026.

    * Filed herewith



    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                   
           
    U.S. PHYSICAL THERAPY, INC.
     
             
    Dated: March 13, 2026
         
    By:
     
    /s/ CAREY HENDRICKSON
     
               
    Carey Hendrickson
     
               
    Chief Financial Officer
     
               
    (duly authorized officer and principal financial and accounting officer)
     



    Get the next $USPH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $USPH

    DatePrice TargetRatingAnalyst
    3/10/2026$102.00Buy
    Jefferies
    9/18/2025$110.00Overweight
    Analyst
    12/16/2024$100.00 → $115.00Neutral → Buy
    BofA Securities
    12/16/2024$113.00Mkt Outperform
    JMP Securities
    10/7/2024$114.00 → $90.00Buy → Neutral
    BofA Securities
    9/22/2023$108.00Overweight
    JP Morgan
    6/30/2023$138.00Buy
    BofA Securities
    12/14/2021$120.00Market Perform → Market Outperform
    CJS Securities
    More analyst ratings

    $USPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO Reeve Graham D. sold $52,205 worth of shares (662 units at $78.86), decreasing direct ownership by 2% to 30,078 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    3/12/26 4:41:09 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by U.S. Physical Therapy Inc.

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    3/11/26 4:38:49 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Hendrickson Carey P returned 10,000 shares to the company, decreasing direct ownership by 26% to 27,808 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    3/10/26 5:21:37 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on U.S. Physical Therapy with a new price target

    Jefferies resumed coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $102.00

    3/10/26 8:43:03 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Analyst resumed coverage on U.S. Physical Therapy with a new price target

    Analyst resumed coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $110.00

    9/18/25 8:45:48 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy upgraded by BofA Securities with a new price target

    BofA Securities upgraded U.S. Physical Therapy from Neutral to Buy and set a new price target of $115.00 from $100.00 previously

    12/16/24 6:45:03 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gilmartin Kathleen A bought $276,000 worth of shares (4,000 units at $69.00), increasing direct ownership by 19% to 24,786 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    11/24/25 4:09:17 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Director Gilmartin Kathleen A bought $172,180 worth of shares (2,000 units at $86.09), increasing direct ownership by 12% to 18,904 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    9/3/24 6:38:08 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Gilmartin Kathleen A bought $82,340 worth of shares (1,000 units at $82.34), increasing direct ownership by 7% to 15,480 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    11/13/23 7:09:28 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. Physical Therapy Presented at the Barclays 28th Annual Global Healthcare Conference

      U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chairman and Chief Executive Officer, presented at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 783 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and r

    3/12/26 7:30:00 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Reports Fourth Quarter and Full Year 2025 Results

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the fourth quarter and full year ended December 31, 2025. FINANCIAL HIGHLIGHTS Year Ended December 31, 2025 versus Year Ended December 31, 2024 Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $95.0 million for the year ended December 31, 2025 ("2025 Year"), an increase of $13.2 million or 16.2%, from $81.8 million for the year ended December 31, 2024 ("2024 Year"). Net income attributable to USPH shareholders ("USPH Net In

    2/25/26 6:28:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year Ended December 31, 2025 Earnings Release and Conference Call Dates

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2025, on Wednesday, February 25, 2026, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 26, 2026. Conference Call Date: Thursday, February 26, 2026   Time: 10:30 am Eastern / 9:30 am Central   Dial-In Number: (800) 445-7795 Primary or   (785) 424-1699 Alternate

    2/11/26 6:30:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    SEC Filings

    View All

    U.S. Physical Therapy Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)

    3/13/26 4:07:53 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)

    3/9/26 4:13:12 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)

    3/3/26 4:28:06 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Financials

    Live finance-specific insights

    View All

    U.S. Physical Therapy Reports Fourth Quarter and Full Year 2025 Results

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the fourth quarter and full year ended December 31, 2025. FINANCIAL HIGHLIGHTS Year Ended December 31, 2025 versus Year Ended December 31, 2024 Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $95.0 million for the year ended December 31, 2025 ("2025 Year"), an increase of $13.2 million or 16.2%, from $81.8 million for the year ended December 31, 2024 ("2024 Year"). Net income attributable to USPH shareholders ("USPH Net In

    2/25/26 6:28:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year Ended December 31, 2025 Earnings Release and Conference Call Dates

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2025, on Wednesday, February 25, 2026, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 26, 2026. Conference Call Date: Thursday, February 26, 2026   Time: 10:30 am Eastern / 9:30 am Central   Dial-In Number: (800) 445-7795 Primary or   (785) 424-1699 Alternate

    2/11/26 6:30:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy Announces the Acquisition of an Industrial Injury Prevention Business

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of an industrial injury prevention business for approximately $15.1 million. The business currently generates approximately $7.0 million in annual revenues. USPH acquired a 70% interest and 30% was retained by the current owner. Eric Williams, President and Chief Operating Officer-East, said, "We are extremely pleased to announce this acquisition today which further expands our offerings in industrial injury prevention service lines. The management team is a perfect fit fo

    2/2/26 4:01:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by U.S. Physical Therapy Inc.

    SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    11/13/24 4:05:19 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by U.S. Physical Therapy Inc.

    SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    10/22/24 3:57:52 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by U.S. Physical Therapy Inc.

    SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    2/14/24 10:04:34 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $USPH
    Leadership Updates

    Live Leadership Updates

    View All

    U.S. Physical Therapy Announces Dual Listing on NYSE Texas

    U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services headquartered in Houston, Texas, today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas, Texas. U.S. Physical Therapy will maintain its primary listing on the New York Stock Exchange and trade with the same "USPH" ticker symbol on NYSE Texas. Chris Reading, Chairman and Chief Executive Officer, said, "We are honored to join NYSE Texas as a Founding Member and to champion the dynamic growth, energy and grit that define this great state. Being

    5/28/25 4:10:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board

    EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue

    6/20/23 8:00:00 AM ET
    $POAI
    $RTX
    $USPH
    Industrial Specialties
    Health Care
    Aerospace
    Industrials

    National Kidney Foundation Appoints Anne Motsenbocker to Board of Directors

    ~Highly Esteemed Growth Strategist and Financial Expert with Decades of Business Acumen~ NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors. We're honored & excited Anne has joined the national board to share her extensive business acumen in board governance.Motsenbocker resides in Dallas, Texas and is a former banker and seasoned board member bringing over 35 years of commercial banking and wealth management expertise due to the numerous roles she held at J

    10/18/22 9:00:00 AM ET
    $CSWI
    $USPH
    Home Furnishings
    Industrials
    Medical/Nursing Services
    Health Care